OCBCO
LGND icon

Oversea-Chinese Banking Corp (OCBC)’s Ligand Pharmaceuticals LGND Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,771
Closed -$632K – 404
2023
Q2 		$632K Buy
+8,771
New +$658K 0.03% 211

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s LGND Position: Q3 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Ligand Pharmaceuticals (LGND) in Q3 2023, closing a stake of 8,771 shares — an estimated $632K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in LGND in Q2 2023 and held it in 1 quarter. The position peaked at $632K in Q2 2023. 196 funds tracked by Wall St. Rank hold LGND as of Q3 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Ligand Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 8,771 Ligand Pharmaceuticals shares in Q3 2023, an estimated $632K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Ligand Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Ligand Pharmaceuticals position peaked at $632K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2023, filed 3 Nov 2023.